|
Market Closed -
OTC Markets
16:19:37 2026-08-13 EDT
|
5-day change | 1st Jan Change | ||
| 3.890 USD | -41.85% |
|
-.--% | -51.43% |
| 09-02 | Evotec, Plectonic Launch Research Collaboration on New T-Cell Approaches for Solid Tumors | MT |
| 09-02 | Evotec, Plectonic Biotech Partner on Research of Novel Immunotherapy for Solid Tumors | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVOTEC SE | Other Biotechnology & Medical Research | -41.85% | -.--% | -51.43% | -44.82% | -92.41% | 663M |
-
|
-
|
-
|
- Stock Market
- Stocks
- EVT Stock
- EVOTF Stock
- Charts Evotec SE
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
